David A. Ricks - 12 Aug 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Signature
/s/ Jonathan Groff for David A. Ricks, pursuant to authorization on file
Issuer symbol
LLY
Transactions as of
12 Aug 2025
Net transactions value
+$1,052,263
Form type
4
Filing time
12 Aug 2025, 16:23:06 UTC
Previous filing
23 Apr 2025
Next filing
10 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ricks David A President, Chair, and CEO, Director LILLY CORPORATE CENTER, INDIANAPOLIS /s/ Jonathan Groff for David A. Ricks, pursuant to authorization on file 12 Aug 2025 0001538604

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Purchase $1,052,263 +1,632 +0.3% $644.77 546,601 12 Aug 2025 Direct F1, F2, F3
holding LLY Common Stock 54,117 12 Aug 2025 By David A. Ricks 2022 GRAT F3
holding LLY Common Stock 300 12 Aug 2025 By Trust F4
holding LLY Common Stock 68,656 12 Aug 2025 By David A. Ricks SLAT F4
holding LLY Common Stock 7,296 12 Aug 2025 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Includes 16 shares previously held in a family member's retirement account.
F3 On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
F4 The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.